Literature DB >> 25457398

Short- and long-term cause of death in patients treated with primary PCI for STEMI.

Frants Pedersen1, Vitalij Butrymovich1, Henning Kelbæk2, Kristian Wachtell1, Steffen Helqvist1, Jens Kastrup1, Lene Holmvang1, Peter Clemmensen1, Thomas Engstrøm1, Peer Grande1, Kari Saunamäki1, Erik Jørgensen1.   

Abstract

BACKGROUND: Short-term mortality has been studied thoroughly in patients undergoing primary percutaneous coronary intervention (PCI), whereas long-term cause of death in patients with ST-segment elevation myocardial infarction (STEMI) remains unknown.
OBJECTIVES: The goal of this study was to describe the association between time and cause of death in patients with STEMI undergoing primary PCI.
METHODS: A centralized civil registration system, patient files, and public disease and death cause registries with an accurate record linkage were used to trace time and cause of death in 2,804 consecutive patients with STEMI (age 63 ± 13 years, 72% males) treated with primary PCI.
RESULTS: Patients were followed up for a median of 4.7 years. During a total of 13,447 patient-years, 717 patients died. Main causes of death within the first 30 days were cardiogenic shock and anoxic brain injury after cardiac arrest. Age, culprit vessel size and flow, and the presence of heart failure and diabetes were independent predictors of mortality. After 30 days, the annual cardiac mortality rate was <1.5%. Causes of death beyond 30 days were noncardiac in 65% of cases (mainly malignancies and pulmonary diseases). The 30-day, 1-year, and 5-year all-cause (and cardiac) mortality rates were 7.9% (7.3%), 11.4% (8.4%), and 23.3% (13.8%), respectively.
CONCLUSIONS: Patients who survive the first month after an STEMI treated with primary PCI have an excellent prognosis, with a <1.5% annual risk of successive cardiac death. Noncardiac causes are responsible for the majority of later deaths in these patients.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute myocardial infarction; cause of death; follow-up study; percutaneous coronary intervention

Mesh:

Year:  2014        PMID: 25457398     DOI: 10.1016/j.jacc.2014.08.037

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  88 in total

1.  Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis.

Authors:  Khagendra Dahal; Aditya Hendrani; Sharan P Sharma; Sampath Singireddy; George Mina; Pratap Reddy; Paari Dominic; Kalgi Modi
Journal:  JAMA Intern Med       Date:  2018-07-01       Impact factor: 21.873

2.  New therapies for reducing post-myocardial left ventricular remodeling.

Authors:  Robert A Kloner; Jianru Shi; Wangde Dai
Journal:  Ann Transl Med       Date:  2015-02

3.  The fall in acute coronary syndrome admissions during the COVID-19 Portuguese lockdown.

Authors:  Daniel Candeias Faria; Miguel Borges Santos; Pedro Farto E Abreu
Journal:  Rev Port Cardiol       Date:  2021-01-02       Impact factor: 1.374

4.  Depressive symptoms, functional measures and long-term outcomes of high-risk ST-elevated myocardial infarction patients treated by primary angioplasty.

Authors:  Leonida Compostella; Sonia Lorenzi; Nicola Russo; Tiziana Setzu; Caterina Compostella; Elia Vettore; Giambattista Isabella; Giuseppe Tarantini; Sabino Iliceto; Fabio Bellotto
Journal:  Intern Emerg Med       Date:  2016-07-12       Impact factor: 3.397

5.  Confocal microscopy and biochemical analysis reveal spatial and functional separation between anandamide uptake and hydrolysis in human keratinocytes.

Authors:  S Oddi; M Bari; N Battista; D Barsacchi; I Cozzani; M Maccarrone
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

6.  Soluble TNF-related apoptosis induced ligand (sTRAIL) is augmented by Post-Conditioning and correlates to infarct size and left ventricle dysfunction in STEMI patients: a substudy from a randomized clinical trial.

Authors:  André Luz; Mário Santos; Rui Magalhães; José Carlos Oliveira; Ana Pacheco; João Silveira; Sofia Cabral; Severo Torres; Adelino F Leite-Moreira; Henrique Carvalho
Journal:  Heart Vessels       Date:  2016-05-26       Impact factor: 2.037

7.  Predictors of all-cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry.

Authors:  Xavier Rossello; Héctor Bueno; Stuart J Pocock; Frans Van de Werf; Nicolas Danchin; Lieven Annemans; Jesús Medina; Uwe Zeymer
Journal:  Clin Cardiol       Date:  2018-12-07       Impact factor: 2.882

8.  Survival benefit from recent changes in management of men and women with ST-segment elevation myocardial infarction treated with percutaneous coronary interventions.

Authors:  Łukasz Zandecki; Marcin Sadowski; Marianna Janion; Jacek Kurzawski; Marek Gierlotka; Lech Poloński; Mariusz Gąsior
Journal:  Cardiol J       Date:  2018-06-20       Impact factor: 2.737

Review 9.  Thrombus aspiration in acute myocardial infarction.

Authors:  Karim D Mahmoud; Felix Zijlstra
Journal:  Nat Rev Cardiol       Date:  2016-03-10       Impact factor: 32.419

10.  Timing and long-term prognosis of recurrent MI after primary angioplasty : Stent thrombosis vs. non-stent-related reinfarction.

Authors:  A Viveiros Monteiro; R Ramos; A Fiarresga; L de Sousa; D Cacela; L Patrício; L Bernardes; C Soares; R Cruz Ferreira
Journal:  Herz       Date:  2016-06-30       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.